Rapport Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
RAPP
CUSIP
75383L102
Type
Equity
Class
COM
Num filings
145
Total reported value, excl. options
$1.48 B
Manager Report Date Value ($000) Shares Option Type